These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11378660)

  • 21. State of mutational alterations of p53 and retinoblastoma susceptibility genes in papillomavirus-negative small cell cervical carcinomas.
    Pao CC; Kao SM; Chen JH; Tang GC; Chang PY; Tan TT
    J Surg Oncol; 1994 Oct; 57(2):87-93. PubMed ID: 7934068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing.
    Kurvinen K; Tervahauta A; Syrjänen S; Chang F; Syrjänen K
    Anticancer Res; 1994; 14(1A):177-81. PubMed ID: 8166446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
    Nagpal JK; Sahni S; Das BR
    Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
    Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
    Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma.
    Kim JW; Cho YH; Lee CG; Kim JH; Kim HK; Kim EJ; Han KT; Namkoong SE
    Acta Oncol; 1997; 36(3):295-300. PubMed ID: 9208900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours.
    Crook T; Wrede D; Tidy JA; Mason WP; Evans DJ; Vousden KH
    Lancet; 1992 May; 339(8801):1070-3. PubMed ID: 1349102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.
    Ngan HY; Tsao SW; Liu SS; Stanley M
    Genitourin Med; 1997 Feb; 73(1):54-8. PubMed ID: 9155557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
    Jiko K; Tsuda H; Sato S; Hirohashi S
    Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of p53 inactivation in human cervical cell carcinoma development.
    Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
    Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck.
    Scholes AG; Liloglou T; Snijders PJ; Hart CA; Jones AS; Woolgar JA; Vaughan ED; Walboomers JM; Field JK
    Int J Cancer; 1997 May; 71(5):796-9. PubMed ID: 9180148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 34. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
    Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa.
    Astori G; Merluzzi S; Arzese A; Brosolo P; de Pretis G; Maieron R; Pipan C; Botta GA
    Digestion; 2001; 64(1):9-14. PubMed ID: 11549832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.
    Münger K; Scheffner M; Huibregtse JM; Howley PM
    Cancer Surv; 1992; 12():197-217. PubMed ID: 1322242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
    Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
    BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
    Tsuda H; Hirohashi S
    Jpn J Cancer Res; 1992 Nov; 83(11):1184-91. PubMed ID: 1336492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.